MS

Mohammad Shaheen

Active Director Director DIN 02043674
DIN 02043674 First appointment Nov 2007 Primary industry Chemicals
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Nov 2007
Shareholding value β€’β€’β€’β€’ Premium profile

About Mohammad Shaheen

Data last updated:

Mohammad Shaheen is a Director at Royal Medpharma India Private Limited (since 2007). The company operates in Chemicals.

DIN 02043674
Primary Designation Director
Industry Chemicals
First Appointment 25 Nov 2007
Oldest Company Age 19 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director25 Nov 20072007Active

Board colleagues of Mohammad Shaheen

Directorship timeline

Open interactive timeline →
Royal Medpharma India Private Limited
Premium access

Shareholding and investment profile for Mohammad Shaheen

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Mohammad Shaheen

Mohammad Shaheen currently holds 1 directorship: Royal Medpharma India Private Limited (Director, since 25 Nov 2007).

Mohammad Shaheen was first appointed on 25 Nov 2007 as Director at Royal Medpharma India Private Limited.

The current boards of Mohammad Shaheen's companies include Mohammad Javeed (Royal Medpharma India Private Limited), Mohammad Kalamunnisa (Royal Medpharma India Private Limited), Salma Haseen (Royal Medpharma India Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available